Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where W T Ruyechan is active.

Publication


Featured researches published by W T Ruyechan.


Journal of Virology | 2001

Varicella-Zoster Virus ORF47 Protein Serine Kinase: Characterization of a Cloned, Biologically Active Phosphotransferase and Two Viral Substrates, ORF62 and ORF63

T. K. Kenyon; J. Lynch; John Hay; W T Ruyechan; Charles Grose

ABSTRACT Varicella-zoster virus (VZV) codes for a protein serine kinase called ORF47; the herpes simplex virus (HSV) homolog is UL13. No recombinant alphaherpesvirus serine kinase has been biologically active in vitro. We discovered that preservation of the intrinsic kinase activity of recombinant VZV ORF47 required unusually stringent in vitro conditions, including physiological concentrations of polyamines. In this assay, ORF47 phosphorylated two VZV regulatory proteins: the ORF62 protein (homolog of HSV ICP4) and the ORF63 protein (homolog of HSV ICP22). Of interest, ORF47 kinase also coprecipitated ORF63 protein from the kinase assay supernatant.


Journal of Virology | 2001

Mutational Analysis of the Repeated Open Reading Frames, ORFs 63 and 70 and ORFs 64 and 69, of Varicella-Zoster Virus

Marvin Sommer; Edward Zagha; Oscar K. Serrano; Chia-chi Ku; Leigh Zerboni; Armin Baiker; Richard A. Santos; Mary Spengler; Jennifer Lynch; Charles Grose; W T Ruyechan; John Hay; Ann M. Arvin

ABSTRACT Varicella-zoster virus (VZV) open reading frame 63 (ORF63), located between nucleotides 110581 and 111417 in the internal repeat region, encodes a nuclear phosphoprotein which is homologous to herpes simplex virus type 1 (HSV-1) ICP22 and is duplicated in the terminal repeat region as ORF70 (nucleotides 118480 to 119316). We evaluated the role of ORFs 63 and 70 in VZV replication, using recombinant VZV cosmids and PCR-based mutagenesis to make single and dual deletions of these ORFs. VZV was recovered within 8 to 10 days when cosmids with single deletions were transfected into melanoma cells along with the three intact VZV cosmids. In contrast, VZV was not detected in transfections carried out with a dual deletion cosmid. Infectious virus was recovered when ORF63 was cloned into a nonnative AvrII site in this cosmid, confirming that failure to generate virus was due to the dual ORF63/70 deletion and that replication required at least one gene copy. This requirement may be related to our observation that ORF63 interacts directly with ORF62, the major immediate-early transactivating protein of VZV. ORF64 is located within the inverted repeat region between nucleotides 111565 and 112107; it has some homology to the HSV-1 Us10 gene and is duplicated as ORF69 (nucleotides 117790 to 118332). ORF64 and ORF69 were deleted individually or simultaneously using the VZV cosmid system. Single deletions of ORF64 or ORF69 yielded viral plaques with the same kinetics and morphology as viruses generated with the parental cosmids. The dual deletion of ORF64 and ORF69 was associated with an abnormal plaque phenotype characterized by very large, multinucleated syncytia. Finally, all of the deletion mutants that yielded recombinants retained infectivity for human T cells in vitro and replicated efficiently in human skin in the SCIDhu mouse model of VZV pathogenesis.


Journal of Virology | 1992

The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles.

Paul R. Kinchington; J K Hougland; Ann M. Arvin; W T Ruyechan; John Hay


The Journal of Infectious Diseases | 1992

Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.

Margaret Sharp; Kehei Terada; Alexandra Wilson; Sonia Nader; Paul E. Kinchington; W T Ruyechan; John Hay; Ann M. Arvin


Journal of Virology | 1986

Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.

Paul R. Kinchington; J Remenick; J M Ostrove; Stephen E. Straus; W T Ruyechan; John Hay


Journal of Virology | 1985

Inversion and circularization of the varicella-zoster virus genome.

Paul R. Kinchington; W Reinhold; T A Casey; Stephen E. Straus; John Hay; W T Ruyechan


Journal of Virology | 1985

Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA.

T A Casey; W T Ruyechan; M N Flora; W Reinhold; Stephen E. Straus; John Hay


Journal of Virology | 1993

Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.

Camille Sabella; Philip W. Lowry; Gina M. Abbruzzi; Celine M. Koropchak; Paul R. Kinchington; Majid Sadegh-Zadeh; John Hay; W T Ruyechan; Ann M. Arvin


Journal of Virology | 1985

DNA-binding proteins present in varicella-zoster virus-infected cells.

C R Roberts; A C Weir; John Hay; Stephen E. Straus; W T Ruyechan


Archive | 2000

Varicella-Zoster Virus: DNA replication

W T Ruyechan; John Hay

Collaboration


Dive into the W T Ruyechan's collaboration.

Top Co-Authors

Avatar

John Hay

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul R. Kinchington

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Stephen E. Straus

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Charles Grose

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge